84 related articles for article (PubMed ID: 21798383)
1. From SELDI-TOF MS to protein identification by on-chip elution.
Mæland Nilsen M; Uleberg KE; Janssen EA; Baak JP; Andersen OK; Hjelle A
J Proteomics; 2011 Nov; 74(12):2995-8. PubMed ID: 21798383
[TBL] [Abstract][Full Text] [Related]
2. An estrogen-responsive plasma protein expression signature in Atlantic cod (Gadus morhua) revealed by SELDI-TOF MS.
Mæland Nilsen M; Meier S; Larsen BK; Ketil Andersen O; Hjelle A
Ecotoxicol Environ Saf; 2011 Nov; 74(8):2175-81. PubMed ID: 21880369
[TBL] [Abstract][Full Text] [Related]
3. SELDI-TOF MS analysis of alkylphenol exposed Atlantic cod with phenotypic variation in gonadosomatic index.
Nilsen MM; Meier S; Andersen OK; Hjelle A
Mar Pollut Bull; 2011 Nov; 62(11):2507-11. PubMed ID: 21945013
[TBL] [Abstract][Full Text] [Related]
4. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
[TBL] [Abstract][Full Text] [Related]
5. Identification of the SELDI ProteinChip human serum retentate by microcapillary liquid chromatography-tandem mass spectrometry.
Zhou M; Prieto DA; Lucas DA; Chan KC; Issaq HJ; Veenstra TD; Conrads TP
J Proteome Res; 2006 Sep; 5(9):2207-16. PubMed ID: 16944932
[TBL] [Abstract][Full Text] [Related]
6. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
[TBL] [Abstract][Full Text] [Related]
7. SELDI-TOF serum proteomics and colorectal cancer: a current overview.
Gemoll T; Roblick UJ; Auer G; Jörnvall H; Habermann JK
Arch Physiol Biochem; 2010; 116(4-5):188-96. PubMed ID: 20615064
[TBL] [Abstract][Full Text] [Related]
8. A proteomic (SELDI-TOF-MS) approach to estrogen agonist screening.
Walker CC; Salinas KA; Harris PS; Wilkinson SS; Watts JD; Hemmer MJ
Toxicol Sci; 2007 Jan; 95(1):74-81. PubMed ID: 16917070
[TBL] [Abstract][Full Text] [Related]
9. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
Geng X; Wang F; Li YG; Zhu GP; Zhang WM
J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
[TBL] [Abstract][Full Text] [Related]
10. Protein detection in dried blood by surface-enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF MS).
Dammann CE; Meyer M; Dammann O; von Neuhoff N
Biol Neonate; 2006; 89(2):126-32. PubMed ID: 16210847
[TBL] [Abstract][Full Text] [Related]
11. Screening for protein adducts of naphthalene and chrysene in plasma of exposed Atlantic cod (Gadus morhua).
Enerstvedt KS; Sydnes MO; Larssen E; Pampanin DM
Chemosphere; 2018 Jun; 200():67-79. PubMed ID: 29475030
[TBL] [Abstract][Full Text] [Related]
12. [Screening of differentially expressed proteins associated with directional highly lymphatic metastasis in ovarian carcinoma cell lines using SELDI-TOF-MS technology].
Guan X; Li DR; Wang Q; Li L; Ruan HY; Zhang W
Ai Zheng; 2008 Nov; 27(11):1155-60. PubMed ID: 19000445
[TBL] [Abstract][Full Text] [Related]
13. In-source decay causes artifacts in SELDI-TOF MS spectra.
Ekblad L; Baldetorp B; Fernö M; Olsson H; Bratt C
J Proteome Res; 2007 Apr; 6(4):1609-14. PubMed ID: 17373843
[TBL] [Abstract][Full Text] [Related]
14. Strategy for purification and mass spectrometry identification of SELDI peaks corresponding to low-abundance plasma and serum proteins.
Fertin M; Burdese J; Beseme O; Amouyel P; Bauters C; Pinet F
J Proteomics; 2011 Apr; 74(4):420-30. PubMed ID: 21184852
[TBL] [Abstract][Full Text] [Related]
15. Biomarker candidate discovery in Atlantic cod (Gadus morhua) continuously exposed to North Sea produced water from egg to fry.
Bohne-Kjersem A; Bache N; Meier S; Nyhammer G; Roepstorff P; Saele O; Goksøyr A; Grøsvik BE
Aquat Toxicol; 2010 Mar; 96(4):280-9. PubMed ID: 20031237
[TBL] [Abstract][Full Text] [Related]
16. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
17. Proteomic profiling of growth hormone-responsive proteins in human peripheral blood leukocytes.
Chung L; Nelson AE; Ho KK; Baxter RC
J Clin Endocrinol Metab; 2009 Aug; 94(8):3038-43. PubMed ID: 19491220
[TBL] [Abstract][Full Text] [Related]
18. Detection of elevated proteins in peritoneal dissemination of gastric cancer by analyzing mass spectra data of serum proteins.
Kojima T; Yoshikawa K; Saga S; Yamada T; Kure S; Matsui T; Uemura T; Fujimitsu Y; Sakakibara M; Kodera Y; Kojima H
J Surg Res; 2009 Jul; 155(1):13-7. PubMed ID: 19394641
[TBL] [Abstract][Full Text] [Related]
19. Biomarker discovery in serum/plasma using surface enhanced laser desorption ionization time of flight (SELDI-TOF) mass spectrometry.
Ndao M
Methods Mol Biol; 2012; 818():67-79. PubMed ID: 22083816
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of Campylobacter species by surface-enhanced laser desorption/ionization-time-of-flight mass spectrometry.
Kiehntopf M; Melcher F; Hänel I; Eladawy H; Tomaso H
Foodborne Pathog Dis; 2011 Aug; 8(8):875-85. PubMed ID: 21524195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
